Aspira Z Score

AWH
 Stock
  

USD 0.73  0.14  23.73%   

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Please continue to Aspira Womans Piotroski F Score and Aspira Womans Valuation analysis.
  
Refresh
Aspira Womans Invested Capital Average is most likely to increase significantly in the upcoming years. The last year's value of Invested Capital Average was reported at 554,500. The current Working Capital is estimated to increase to about 34.7 M, while Capital Expenditure is projected to decrease to (198.5 K). Aspira Womans Interest Expense is most likely to decrease significantly in the upcoming years. The last year's value of Interest Expense was reported at 48,000. The current Research and Development Expense is estimated to increase to about 5.7 M, while Consolidated Income is projected to decrease to (32.5 M).

Aspira Z Score Analysis

Aspira Womans' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 2019 2020 2021 2022 (projected)
Revenues USD4.54 M4.65 M6.81 M5.49 M
Revenues4.54 M4.65 M6.81 M5.49 M
Z Score 
 = 
Sum Of  
 
5 Factors 
More About Z Score | All Equity Analysis

Current Aspira Womans Z Score

    
  12.6  
Most of Aspira Womans' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aspira Womans Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
First Factor
 = 
1.2 * (
Working Capital
/
Total Assets )
Second Factor
 = 
1.4 * (
Retained Earnings
/
Total Assets )
Thrid Factor
 = 
3.3 * (
EBITAD
/
Total Assets )
Fouth Factor
 = 
0.6 * (
Market Value of Equity
/
Total Liabilities )
Fifth Factor
 = 
0.99 * (
Revenue
/
Total Assets )

Aspira Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Aspira Womans is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Aspira Womans' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aspira Womans' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aspira Womans' interrelated accounts and indicators.
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition
In accordance with the company's disclosures, Aspira Womans Health has a Z Score of 12.6. This is 86.67% higher than that of the sector and 278.38% higher than that of the Z Score industry. The z score for all United States stocks is 44.5% lower than that of the firm.

Aspira Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aspira Womans' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aspira Womans could also be used in its relative valuation, which is a method of valuing Aspira Womans by comparing valuation metrics of similar companies.
Aspira Womans is currently under evaluation in z score category among related companies.

Aspira Womans Current Valuation Drivers

We derive many important indicators used in calculating different scores of Aspira Womans from analyzing Aspira Womans' financial statements. These drivers represent accounts that assess Aspira Womans' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aspira Womans' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(262.43 K)(264.44 K)(287.49 K)(258.78 K)(293.17 K)(316.31 K)
Revenue Per Employee78.03 K71 K85.62 K67.22 K63.07 K75.94 K
Average Assets8.95 M11.61 M14.19 M16.08 M51.81 M55.9 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(9.67 M)(10.67 M)(14.9 M)(17.62 M)(31.27 M)(32.1 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(9.67 M)(10.67 M)(14.9 M)(17.62 M)(31.27 M)(32.1 M)
Earnings before Tax(10.5 M)(11.37 M)(15.24 M)(17.91 M)(31.66 M)(32.5 M)
Average Equity5.1 M7.54 M9.39 M9.21 M41.96 M45.27 M
Enterprise Value109.76 M12.38 M65.47 M682.16 M156.73 M148.04 M
Free Cash Flow(15.22 M)(8.19 M)(9.48 M)(13.1 M)(27.58 M)(28.3 M)
Invested Capital1.01 M565 K(206 K)2.14 M(84 K)(90.63 K)
Invested Capital Average1.58 M866.75 K(132.25 K)544.25 K554.5 K598.28 K
Market Capitalization115.8 M22.61 M78.76 M698.42 M198.46 M179.28 M
Tangible Asset Value7.5 M11.41 M13.83 M19.61 M41.08 M32.62 M
Working Capital3.7 M7.82 M9.43 M12.6 M32.16 M34.7 M

Aspira Womans Institutional Holders

Institutional Holdings refers to the ownership stake in Aspira Womans that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aspira Womans' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aspira Womans' value.
Security TypeSharesValue
Blackrock IncCommon Shares4.7 M4.9 M
Vanguard Group IncCommon Shares3.1 M3.2 M
Oracle Investment Management IncCommon Shares2.1 M2.2 M
State Street CorpCommon Shares1.8 M1.9 M
Geode Capital Management LlcCommon Shares1.1 M1.2 M
Renaissance Technologies LlcCommon Shares1.1 M1.2 M
Act Capital Management LlcCommon Shares1000 KM

Aspira Fundamentals

About Aspira Womans Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Aspira Womans Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aspira Womans using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aspira Womans Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Aspira Womens Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira Womens Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas. Aspira Womans operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 106 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aspira Womans without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Pair Trading with Aspira Womans

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspira Womans position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspira Womans will appreciate offsetting losses from the drop in the long position's value.

Aspira Womans Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Aspira Womans could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspira Womans when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspira Womans - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspira Womans Health to buy it.
The correlation of Aspira Womans is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspira Womans moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspira Womans Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspira Womans can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Aspira Womans Piotroski F Score and Aspira Womans Valuation analysis. Note that the Aspira Womans Health information on this page should be used as a complementary analysis to other Aspira Womans' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Aspira Stock analysis

When running Aspira Womans Health price analysis, check to measure Aspira Womans' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspira Womans is operating at the current time. Most of Aspira Womans' value examination focuses on studying past and present price action to predict the probability of Aspira Womans' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aspira Womans' price. Additionally, you may evaluate how the addition of Aspira Womans to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Aspira Womans' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aspira Womans. If investors know Aspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aspira Womans listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
82.2 M
Quarterly Revenue Growth YOY
0.27
Return On Assets
-0.48
Return On Equity
-0.95
The market value of Aspira Womans Health is measured differently than its book value, which is the value of Aspira that is recorded on the company's balance sheet. Investors also form their own opinion of Aspira Womans' value that differs from its market value or its book value, called intrinsic value, which is Aspira Womans' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aspira Womans' market value can be influenced by many factors that don't directly affect Aspira Womans' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aspira Womans' value and its price as these two are different measures arrived at by different means. Investors typically determine Aspira Womans value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aspira Womans' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.